A Model Practice must be responsive to a particular local public health problem or concern. An innovative practice must be -
Please state the Responsiveness and Innovation of your practice
Responsiveness and Innovation
DOH-Broward understood the need for community provider support in order for this program to be effective and contacted AIDS Healthcare Foundation (AHF) to form a partnership to operationally achieve the state of Florida’s programmatic mandate to provide PrEP services by December 31, 2018. This innovative approach focused on synergistically leveraging the existing partnership between DOH-Broward and AHF through shared operation of the sexual health wellness clinic; Broward Wellness Center (BWC). The Rapid-PrEP Program represents a successful public/private sector collaboration that attains core operational efficiencies via utilization of: 1) existing physical STD clinic sexual health and wellness resources to incorporate same-day PrEP services; 2) trained STD clinic counseling/testing staff and physicians, as well as; 3) a newly constructed on-site pharmacy, PrEP via-mail services and pharmacy staff to process/obtain third-party PrEP financial support. In addition, Rapid-PrEP Program representatives demonstrate value-added innovation in the delivery of PrEP client services by providing linkage to ancillary to essential support services for those at highest risk of acquiring HIV, as prioritized by CDC funding announcement PS 18-1802.
Statement of the problem/public health issue
According to the CDC, the Fort Lauderdale Division of the Miami Metropolitan Statistical Area (MSA) has the second highest rate of new HIV infections (40.1/100,000 persons) and the third highest AIDS case rates in the United States (18.9/100,000 persons). In 2018, Broward County had an estimated 21,048 people living with HIV (PLWH).
The CDC’s PS18-1802 funding announcement outlines activities for the prevention and treatment of HIV, which includes targeted HIV prevention efforts to HIV-negative persons at risk for infection are also important. These efforts supplement prevention efforts among persons living with HIV to help prevent new HIV infections as well as other sexually transmitted infection not protected by anti-retroviral (ART) medications. This includes support for community-level HIV prevention activities, PrEP, and other targeted prevention strategies. PrEP is a highly effective intervention that can reduce the number of new HIV infections when supported by behavioral and structural strategies.
What target population is affected by problem (please include relevant demographics)
The top priority populations based on persons living with HIV disease (HIV incidence surveillance data) are the following:
- Black Heterosexual men and women
- White Men who have Sex with Men (MSM)
- Hispanic MSM
- Black MSM
- Hispanic Heterosexual men and women
- White Injection Drug Use (IDU)
- White heterosexual men and women
- Black IDU
- Hispanic IDU
What is the target population size?
The DOH-Broward/AHF contract to provide services at Broward Wellness Center (BWC) for 7,200 Rapid-PrEP clinical visits annually which included follow-up visits at no cost to the client. An adherent client would receive and average of three follow-up visits in a 12-month period including the initial visit. Therefore, our target population for this project period has a baseline of 1,800 new patients. Benchmarking with national averages of approximately 40% adherence (e.g. San Francisco and New York City), DOH-Broward will continuously enroll new clients, monitor and track adherence.
What percentage did you reach?
Broward County is a minority/majority county demonstrated by its population by race (Black 28.5%, Asian 3.6%, Hispanic 26.9%, more than one race .2%, and White 40.8%)
From June 1, 2018 to November 8, 2019, a total of 2,477 individuals received same-day starter packs of PrEP during their initial visit to our clinic through the Rapid-PrEP Program. Of those that received a starter-pack, 1,886 (76%) were eligible for and enrolled into PrEP Navigation services. Return for follow-up visits and pharmacy pick up is the current best indicator for adherence and currently, which shows a 40% adherence rate.
Of those that initiated the program, 82.8% were Male (29.0% non-Hispanic White, 22.5% non-Hispanic Black and 43.9% Hispanic); 15.3% Female (16.9% non-Hispanic White, 52.1% non-Hispanic Black, and 29.1% Hispanic); and 1.9% Transgender (19.6% non-Hispanic White, 26.1% non-Hispanic Black, and 50.0% Hispanic). Most individuals were between the age ranges of 20-29 (43.5%), 30-39 (28.3%) and 40-49 (12.9%) and 44% had private insurance while 56% received patient assistance program (PAP) medication assistance.
The specific factors that led to the success of Rapid-PrEP were the following: 1) utilization of incident command system; 2) ongoing engagement and training of navigators, HIV testing counselors, and stakeholders; 3) Leveraging an on-site pharmacy; 4) intensive monitoring and client engagement during the first thirty days; 5) provision of transportation services, and; 6) one-stop shop services location 7) no cost regardless of the ability to paid (no sliding fee scales).
What has been done in the past to address the problem?
The Nation’s first comprehensive National HIV/AIDS Strategy (Strategy) for the United States was released in 2010. In the subsequent five years, people and organizations have joined together around its vision and goals. The Strategy has changed the way the American people talk about HIV, prioritize and organize prevention and care services locally, and deliver clinical and non-clinical services that support people living with HIV to remain engaged in care, and has helped to achieve many things, but namely the introduction of PrEP (pre-exposure prophylaxis), a much-needed new biomedical prevention tool that helps people reduce their risk of HIV infection by taking a daily pill. Based on evidence from multiple clinical trials released from 2011 to 2013, the Food and Drug Administration (FDA) approved PrEP in 2012. In 2014, the U.S. Public Health Service issued clinical practice guidelines for PrEP. Based on scientific and technological advances in the past five years, new guidelines and recommendations have expanded the number of options for prevention. CDC issued guidance to providers recommending PrEP be considered for those at substantial risk for HIV. In addition, guidelines from the U.S. Department of Health and Human Services (HHS) now recommend that all persons with HIV be offered treatment not only for their own health, but also because antiretroviral treatment significantly reduces the risk of HIV transmission to others. Additionally, the U.S. Preventive Services Task Force (USPSTF) recommends that all people aged 15 to 65 years and all pregnant women be screened for HIV. CDC also provided guidance for the adoption of new testing technologies that enhance the ability to diagnose HIV soon after infection, broadening the window of opportunity for effective interventions during the acute phase of infection—a time when HIV is most likely to be transmitted to others. Over the next five years sustained effort is required to realize the promise of these and other scientific advances, and to adopt and embrace emerging beneficial research findings. These may include the availability of sustained release antiretroviral agents either for PrEP or for treatment, new developments in microbicides or vaccines, or more effective delivery of HIV care services.
Historically, PrEP has been more accessible by individuals with commercial insurance and higher social-economic statuses than Broward County’s priority populations. Even with drug manufacturer reduced co-pay cards, the cost of PrEP and subsequent follow-ups has been a major deterrent for individuals seeking PrEP services. Few medical providers in Broward County treat indigent or uninsured patients. Federally Qualified Healthcare Centers (FQHC’s) and Local Health Departments (LHD’s) needed innovative ways to address the growing demand of the community seeking to access PrEP Services, thus causing excessive burden and saturation of services for the public sector and its resources. Lastly, early PrEP program data nationally demonstrated that PrEP adherence was extremely low. A deterent factor was the necessity for individuals to return every three months to their medical provider and take a daily medication was a major barrier in justifying the efficacy of early PrEP programs.
Why is the current/proposed practice better?
The Rapid-PrEP model is effective because it eliminates key barriers to the access of PrEP at point of care, especially for members of the priority populations at highest-risk of acquiring HIV in Broward County. By providing same-day PrEP medication and laboratory tests at no-cost to the patient, individuals are more likely to request, accept, or re-enroll in PrEP Services at the Broward Wellness Center (BWC). Another key element of the Rapid-PrEP program is that it uses highly-trained service navigators that, during the initial intake, provide adherence counseling, motivational interviewing techniques for risk-reduction, and thoroughly review and submit necessary documentation required to continue to provide the medication at no-cost to the patient (i.e. third party or manufacturer assistance programs). Additionally, the Rapid-PrEP program has an on-site pharmacy (a key element of our public/private partnership in the community) that can offer services such as free delivery of medication, renewal of assistance programs, and supply the feedback mechanism to monitor and measure adherence such as client pick up at months 1, 2, 3, etc. Once enrolled in the PrEP Program, PrEP Navigators closely monitor clients by completing a 3-day and 1-month follow-up contact within the first 30-days of PrEP initiation. During these interactions with the clients, adherence, side-effects, and any additional barriers are assessed and mitigated. Additionally, PrEP Navigators provide referral and linkage services for individuals that request or need such services that include transportation, housing, mental health, substance use treatment, employment and other services.
In this way, the DOH-Broward PrEP Program combined the CDC’s PS 18-1802 funding announcement guidance, the Florida’s Plan to eliminate HIV-transmission and HIV-related deaths, and the NHAS 2020 guidance in order to establish benchmark goals and objectives based on national leaders’ such as New York City Department of Health and Mental Hygiene and San Francisco Department of Public Health, which innovated PrEP service delivery in our county and subsequently the state of Florida.
Please see CDC’s MMWR Reports for Providers for additional information on these programs:
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6446a4.htm?s_cid=mm6446a4_w https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6446a5.htm?s_cid=mm6446a5_w
Clinical Guidelines for providers can be found here:
https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf